drugset / Trial / NCT00418249
Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to assess the safety and efficacy of topical AS101 as treatment for Female Androgenetic Alopecia (FAGA) in menopause women.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TRICHLOROTELLURATE | Small molecule | — | Topical |